In addition, as a downstream gene of SOX4, DHX9 activates the Wnt/β-catenin signaling pathway then promotes tumor metastasis and drug resistance (Jiang et al., 2007; Gupta et al., 2010; Thiago et al., 2010; Lai et al., 2011). This evidence concerns the gene SOX4 and neoplasm.